首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:South asian journal of cancer

缩写:

ISSN:2278-330X

e-ISSN:2278-4306

IF/分区:0.6/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引955
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Krishna Prasad,Sanath Hegde,Suresh Rao et al. Krishna Prasad et al.
In the curative treatment of cancer with adjuvant chemotherapy, antineoplastic drugs, along with glucocorticoids, can induce hyperglycemia. The objective of this study was to assess the utility of the Indian Diabetes Risk Score (IDRS) in pr...
Bhagyashri R Patil-Takbhate,Swati D Bhakare Bhagyashri R Patil-Takbhate
Self-vaginal sampling (SVS) is a promising tool for cervical cancer prevention, offering a convenient and cost-effective alternative to traditional screening. With an 80% lifetime risk of HPV infection among women, SVS improves accessibilit...
Amit Kumar,Akhil Kapoor,Vanita Noronha et al. Amit Kumar et al.
Background: Immunotherapy has improved outcomes in many advanced solid tumors. In resource-constrained settings, less than 2% of patients can afford standard dose immunotherapy. A recent phase II study showed the efficacy...
Purvish M Parikh,Ghanashyam Biswas,Nilesh Ashok Dhamne et al. Purvish M Parikh et al.
Head and neck squamous cell carcinoma (HNSCC) is the most common malignancy group in India and several other low- and middle-income countries. Currently, majority of the patients present in advanced stage where systemic therapy is standard ...
Randhir Singh Ranta,Sakshi Sharma,Manoj Chauhan Randhir Singh Ranta
Objective: This study investigated the distribution of cancer cases across different age groups, sexes, and regions in Himachal Pradesh, India, with the aim of informing targeted public health strategies. ...
Purvish M Parikh,Amish Vora,Rajan Yadav et al. Purvish M Parikh et al.
It is still not possible for all patients with early breast cancer to be cured. Even when they respond well to initial therapy, there exists a substantial risk for recurrence, sometimes after several years. With the availability of cyclin-d...
S Shanthala,Usha Amirtham,K N Lokesh et al. S Shanthala et al.
Metastatic breast cancer (MBC) is an incurable disease with the primary aim of treatment being the improvement of the patient's quality of life and the delay of disease progression. A substantial proportion of patients with hormone receptor...
V Seenu,Pratibha Kole,Suman Dhabal V Seenu
Cancer patients often present after a period of certain delay from onset of symptoms. By tradition, alternate medicine has been the commonly sought after remedy for them. The objective of this study was to evaluate the delay in presentation...
Sandeep B Shinde,Pooja P Jain,Diksha S Jagwani et al. Sandeep B Shinde et al.
Breast cancer (BC) is one of the most frequent cancers in women, and breast cancer-related lymphedema (BCRL) is a common side effect of BC treatment. When the lymphatic drainage system is damaged, lymphedema develops, which further exacerba...